GDF15 and myeloid sarcoma: We found no statistically significant change in blood levels of C-reactive protein, total protein, total cholesterol, triglycerides, HDL, TSH, GDF-15, FGF-21, Testosterone, IL-6, IL-8, Follistatin, and IGF-1, including between SS-group and MS-group sera.